Estrogen Receptor Beta in Cancer: an Attractive Target for Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|19|2734-2757

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.19, 2012-06, pp. : 2734-2757

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Estrogen Receptor Expression and its Relevant Signaling Pathway in Prostate Cancer: A Target of Therapy

By  

Current Molecular Pharmacology, Vol. 5, Iss. 3, 2012-11 ,pp. : 392-400

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylation: An Attractive Target for Cancer Therapy?

By Al-Janadi Anas   Chandana Sreenivasa R.   Conley Barbara A.  

Drugs in R&D, Vol. 9, Iss. 6, 2008-01 ,pp. : 369-383

Adis International

Access to resources Recommend Favorite

Gene Expression Profiles in Breast Cancer to Identify Estrogen Receptor Target Genes

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 5, 2008-05 ,pp. : 448-454

Bentham Science Publishers

Access to resources Recommend Favorite

The NK-1 Receptor: A New Target in Cancer Therapy

By  

Current Drug Targets, Vol. 12, Iss. 6, 2011-06 ,pp. : 909-921

Bentham Science Publishers

Access to resources Recommend Favorite

Receptor Tyrosine Kinases as Target for Anti-Cancer Therapy

By  

Current Pharmaceutical Design, Vol. 8, Iss. 22, 2002-10 ,pp. : 1959-1972

Bentham Science Publishers

Access to resources Recommend Favorite